Shargel 8e AppC
Shargel 8e AppC
Aciphex Eisai ec
Adalat CC Schering Plough sr
Adderall XR Shire US sr
Advicor KOS sr
Aerohist Aero sr
Aerohist Plus Aero sr
Afeditab CR Watson sr
Aggrenox Boehr, Ingelheim sr
Aldex Zyber sr
Aldex-G Zyber sr
Aleve Cold & Sinus Bayer Healthcare sr
Aleve Sinus & Headache Bayer Healthcare sr
Allegra-D 12 Hour Sanofi-Aventis sr
Allegra-D 24 Hour Sanofi-Aventis sr
Allerx Cornerstone sr
Allerx-D Cornerstone sr
Allfen MCR American sr
Allfen-DM MCR American sr
Alophen Numark ec
Altex-PSE Alphagen sr
Altoprev First Horizon sr
Ambi 1000/55 Ambi sr
Ambi 45/800 Ambi sr
Ambi 45/800/30 Ambi sr
Ambi 60/580 Ambi sr
Ambi 60/580/30 Ambi sr
Ambi 80/700 Ambi sr
D-Feda II WE Pharm. sr
Diabetes Trio Mason Vitamins sr
Diamox Sequels Duramed sr
Dilacor XR Watson sr
Dilantin Kapseals Pfizer sr
Dilatrate-SR Schwarz Pharma sr
Diltia XT Andrx sr
Dilt-XR Apotex sr
Dimetane Extentabs Wyeth sr
Disophrol Chronotab Schering Plough sr
Ditropan XL Ortho-McNeil sr
Donnatal Extentabs PBM sr
Doryx Warner Chilcott ec
Drexophed SR Qualitest sr
Drihist SR Prasco sr
Drixomed lopharm sr
Drixoral Schering Plough sr
Drixoral Plus Schering Plough sr
Drixoral Sinus Schering Plough sr
Drize-R Monarch sr
Drysec A. G. Marin sr
Dulcolax Boehr, Ingelheim ec
Duomax Capellon sr
Duradex Proethic sr
Duradryl Jr Breckenridge sr
Durahist Proethic sr
Durahist D Proethic sr
Durahist PE Proethic sr
Duraphen DM Proethic sr
Duraphen Forte Proethic sr
Duraphen II Proethic sr
Duraphen II DM Proethic sr
Duratuss Victory sr
Duratuss GP Victory sr
Dynabac Muro ec
Dynabac D5-Pak Muro ec
Dynacirc CR Reliant sr
Dynahist-ER Pediatric Breckenridge sr
Dynex Athlon sr
Dytan-CS Hawthorn sr
Easprin Harvest ec
EC Naprosyn Roche ec
Ecotrin GlaxoSmithKline ec
Ecotrin Adult Low Strength GlaxoSmithKline ec
Ecotrin Maximum Strength GlaxoSmithKline ec
Ecpirin Prime Marketing ec
Ed A-Hist Edwards sr
Ed-Chlor-Tan Edwards sr
Effexor-XR Wyeth sr
Efidac 24 Chlorpheniramine Novartis Consumer sr
Efidac 24 Pseudoephedrine Novartis Consumer sr
Enablex Novartis sr
Endal Pediamed sr
Appendix C 1259
Entab-DM Rising sr
Entercote Global Source ec
Entex ER Andrx sr
Entex LA Andrx sr
Entex PSE Andrx sr
Entocort EC Prometheus ec
Equetro Shire US sr
ERYC Warner Chilcott ec
Ery-Tab Abbott ec
Eskalith-CR GlaxoSmithKline sr
Exefen-DM Larken sr
Exefen-PD Larken sr
Extendryl Jr Fleming sr
Extendryl SR Fleming sr
Extress-30 Key sr
Extuss LA Cypress sr
Feen-A-Mint Schering Plough ec
Femilax G&W ec
Fero-Folic-500 Abbott sr
Fero-Grad-500 Abbott sr
Ferro-Sequels Inverness Medical sr
Ferro-Time Time-Cap sr
Ferrous Fumarate DS Vita-Rx sr
Fetrin Lunsco sr
Flagyl ER Pharmacia sr
Fleet Bisacodyl Fleet, C. B. ec
Focalin XR Novartis sr
Folitab 500 Rising sr
Fortamet First Horizon sr
Fumatinic Laser sr
G/P 1200/75 Cypress sr
Genacote Ivax ec
GFN 1000/DM 50 Cypress sr
GFN 1200/DM 20/PE 40 Cypress sr
GFN 1200/DM 60/PSE 60 Cypress sr
GFN 1200/Phenylephrine 40 Cypress sr
GFN 1200/PSE 50 Cypress sr
GFN 500/DM 30 Cypress sr
GFN 550/PSE 60 Cypress sr
GFN 550/PSE 60/DM 30 Cypress sr
GFN 595/PSE 48 Cypress sr
GFN 595/PSE 48/DM 32 Cypress sr
GFN 795/PSE 85 Cypress sr
GFN 800/DM 30 Cypress sr
GFN 800/PE 25 Cypress sr
GFN 800/PSE 60 Cypress sr
Gilphex TR Gil sr
Giltuss TR Gil sr
Glucophage XR Bristol-Myers Squibb sr
Glucotrol XL Pfizer sr
GP-1200 lopharm sr
Guaifed Victory sr
Guaifed-PD Victory sr
Guaifenex DM Ethex sr
Guaifenex GP Ethex sr
Guaifenex PSE 120 Ethex sr
Guaifenex PSE 60 Ethex sr
Guaifenex PSE 80 Ethex sr
Guaimax-D Schwarz Pharma sr
Gua-SR Seatrace sr
Guia-D Breckenridge sr
Guiadex D Breckenridge sr
Guiadex PD Breckenridge sr
Guiadrine DM Breckenridge sr
Guiadrine G-1200 Breckenridge sr
Guiadrine GP Breckenridge sr
Guiadrine PSE Breckenridge sr
H 9600 SR Hawthorn sr
Halfprin Kramer ec
Hemax Pronova sr
Histacol LA Breckenridge sr
Histade Breckenridge sr
Histade MX Breckenridge sr
Hista-Vent DA Ethex sr
Hista-Vent PSE Ethex sr
Histex CT Teamm sr
Histex I/E Teamm sr
Histex SR Teamm sr
Humavent LA WE Pharm. sr
Humibid DM Carolina sr
Humibid L.A. Carolina sr
Hydro Pro DM SR Breckenridge sr
Hyoscyamine TR Breckenridge sr
Iberet-500 Abbott sr
Iberet-Folic-500 Abbott sr
Icar-C Plus SR Hawthorn sr
Imdur Schering Plough sr
Inderal LA Wyeth sr
Indocin SR Forte Pharma sr
Innopran XL Reliant sr
Iobid DM Iopharm sr
Ionamin Celltech sr
Iosal II Iopharm sr
Iotex PSE Iopharm sr
Isochron Forest sr
Isoptin SR FSC sr
Kadian Alphagen sr
Kaon-CI 10 Savage sr
K-Dur 10 Schering Plough sr
K-Dur 20 Schering Plough sr
Klor-Con 10 Upsher-Smith sr
Klor-Con 8 Upsher-Smith sr
Klor-Con M10 Upsher-Smith sr
Klor-Con M15 Upsher-Smith sr
Klor-Con M20 Upsher-Smith sr
Klotrix Bristol-Myers Squibb sr
Appendix C 1261
Kronofed-A Ferndale sr
Kronofed-A-Jr Ferndale sr
K-Tab Abbott sr
K-Tan Prasco sr
Lescol XL Novartis sr
Levall G Athlon sr
Levbid Schwarz Pharma sr
Levsinex Schwarz Pharma sr
Lexxel Astra Zeneca sr
Lipram 4500 Global ec
Lipram-CR10 Global ec
Lipram-CR20 Global ec
Lipram-CR5 Global ec
Lipram-PN10 Global ec
Lipram-PN16 Global ec
Lipram-PN20 Global ec
Lipram-UL12 Global ec
Lipram-UL18 Global ec
Lipram-UL20 Global ec
Liquibid-D Capellon sr
Liquibid-D 1200 Capellon sr
Liquibid-PD Capellon sr
Lithobid JDS Pharm. sr
Lodine XL Wyeth sr
Lodrane 12 Hour ECR sr
Lodrane 12D ECR sr
Lodrane 24 ECR sr
Lohist-12 Larken sr
Lohist-12D Larken sr
Lusonex Wraser sr
Mag Delay Major ec
Mag64 Rising ec
Mag-SR Cypress sr
Mag-SR Plus Calcium Cypress sr
Mag-Tab SR Niche sr
Maxifed MCR American sr
Maxifed DM MCR American sr
Maxifed DMX MCR American sr
Maxifed-G MCR American sr
Maxiphen DM Ambi sr
Maxovite Tyson Neutraceuticals sr
Medent DM Stewart-Jackson sr
Medent LD Stewart-Jackson sr
Mega-C Merit sr
Melfiat Numark sr
Menopause Trio Mason Vitamins sr
Mestinon Timespan Valeant sr
Metadate CD Celltech sr
Metadate ER Celltech sr
Methylin ER Mallinckrodt sr
Micro-K Ther-Rx sr
Micro-K 10 Ther-Rx sr
Mild-C Carlson, J. R. sr
Mindal Breckenridge sr
Mindal DM Breckenridge sr
Mintab C Breckenridge sr
Mintab D Breckenridge sr
Mintab DM Breckenridge sr
Miraphen PSE Caraco sr
Modane Savage ec
MS Contin Purdue sr
MSP-BLU Cypress ec
Mucinex Adams sr
Mucinex D Adams sr
Muco-Fen DM Ivax sr
Multi-Ferrous Folic United Research sr
Multiret Folic-500 Amide sr
Myfortic Novartis ec
Nacon Cypress sr
Nalex-A Blansett sr
Naprelan Blansett sr
Nasatab LA ECR sr
Nasex Cypress sr
Nd Clear Seatrace sr
Nescon-PD Cypress sr
New Ami-Tex LA Amide sr
Nexium Astra Zeneca ec
Niaspan KOS sr
Nicomide Sirius sr
Nifediac CC Teva sr
Nifedical XL Teva sr
Nitrocot Truxton sr
Nitro-Time Time-Cap sr
Nohist Larken sr
Norel SR U.S. Pharm. Corp. sr
Norpace CR Pharmacia sr
Obstetrix EC Seyer Pharmatec ec
Omnihist L.A. WE Pharm. sr
Opana ER Endo sr
Oramorph SR AAI Pharma sr
Oracea Collagenex sr
Oruvail Wyeth sr
Oxycontin Purdue sr
Palcaps 10 Breckenridge ec
Palcaps 20 Breckenridge ec
Palgic-D Pamlab sr
Pancrease McNeil Consumer ec
Pancrease MT 10 McNeil Consumer ec
Pancrease MT 16 McNeil Consumer ec
Pancrease MT 20 McNeil Consumer ec
Pancrecarb MS-16 Digestive Care ec
Pancrecarb MS-4 Digestive Care ec
Pancrecarb MS-8 Digestive Care ec
Pangestyme CN-10 Ethex ec
Pangestyme CN-20 Ethex ec
Pangestyme EC Ethex ec
Appendix C 1263
Protonix Wyeth ec
Prozac Weekly Eli Lilly ec
Pseubrom Alphagen sr
Pseubrom-PD Alphagen sr
Pseudatex Breckenridge sr
Pseudocot-C Truxton sr
Pseudocot-G Truxton sr
Pseudovent Ethex sr
Pseudovent 400 Ethex sr
Pseudovent DM Ethex sr
Pseudovent PED Ethex sr
P-Tuss DM Prasco sr
Qdall Atley sr
Quibron-T/SR Monarch sr
Quindal Qualitest sr
Ralix Cypress sr
Ranaxa CV Therapeutics sr
Razadyne ER Ortho-McNeil sr
Reliable Gentle Laxative Ivax ec
Rescon-Jr Capellon sr
Rescon-MX Capellon sr
Respa-1ST Respa sr
Respa-AR Respa sr
Respa-DM Respa sr
Respahist Respa sr
Respaire-120 SR Laser sr
Respaire-60 SR Laser sr
Respa-PE Respa sr
Rhinabid Breckenridge sr
Rhinabid PD Breckenridge sr
Rhinacon A Breckenridge sr
Ribo-2 Tyson Neutraceuticals ec
Risperdal Consta Janssen sr
Ritalin LA Novartis sr
Ritalin-SR Novartis sr
Rodex Forte Legere sr
Rondec-TR Biovail sr
Ru-Tuss 800 Sage sr
Ru-Tuss 800 DM Sage sr
Ru-Tuss Jr Sage sr
Ryneze Stewart-Jackson sr
Rythmol SR Reliant sr
Sam-E Pharmavite ec
Sinemet CR Bristol-Myers Squibb sr
Sinutuss DM WE Pharm. sr
Sinuvent PE WE Pharm. sr
Sitrex Vindex sr
Slo-Niacin Upsher-Smith sr
Slow Fe Novartis Consumer sr
Slow Fe With Folic Acid Novartis Consumer sr
Slow-Mag Purdue ec
Solodyn Medicis sr
Spacol T/S Dayton sr
Appendix C 1265
Urimax Xanodyne ec
Uritact-EC Cypress ec
Urocit-K 10 Mission sr
Urocit-K 5 Mission sr
Uroxatral Sanofi-Aventis sr
Utira Hawthorn sr
V-Dec-M Seatrace sr
Veracolate Numark ec
Verelan Schwarz Pharma sr
Verelan PM Schwarz Pharma sr
Versacaps Seatrace sr
Videx EC Bristol-Myers Squibb ec
Vivotif Berna Berna Products ec
Voltaren Novartis ec
Voltaren-XR Novartis sr
Vospire Dava sr
Vospire ER Odyssey sr
We Mist II LA WE Pharm. sr
We Mist LA WE Pharm. sr
Wellbid-D Prasco sr
Wellbid-D 1200 Prasco sr
Wellbutrin SR GlaxoSmithKline sr
Wellbutrin XL GlaxoSmithKline sr
Wobenzym N Marlyn ec
Xanax XR Pharmacia sr
Xiral Hawthorn sr
XpeCT-At Hawthorn sr
XpeCT-HC Hawthorn sr
Z-Cof LA Zyber sr
Z-Cof LAX Zyber sr
Zephrex LA Sanofi-Aventis sr
Zmax Pfizer sr
Zorprin Par sr
Zyban GlaxoSmithKline sr
Zymase Organon ec
Zyrtec-D Pfizer sr
Reprinted with permission from The Drug Topics Red Book. Montvale NJ: Thomson Medical Economics, 2007.
Analgesics Manufacturer
Antacids/Antiflatulents
Antiasthmatic/Respiratory Agents
Antidiarrheals
Corticosteroids
Cough/Cold/Allergy Preparations
Fluoride Preparations
Laxatives
Miscellaneous
Mouth/Throat Preparations
Potassium Supplements
Reprinted with permission from The Drug Topics Red Book. Montvale NJ: Thomson Medical Economics, 2007.
ALCOHOL-FREE PRODUCTS eneric and alternate brands may exist. Always check
G
The following is a selection of alcohol-free products product labeling for definitive information on specific
by therapeutic category. The list is not comprehensive. ingredients.
Analgesics Manufacturer
Antiasthmatic Agents
Anticonvulsants
Antiviral Agents
Cough/Cold/Allergy Preparations
Ear/Nose/Throat Products
Gastrointestinal Agents
Hematinics
Miscellaneous
Psychotropics
Topical Products
Vitamins/Minerals/Supplements
Reprinted with permission from The Drug Topics Red Book. Montvale NJ: Thomson Medical Economics, 2007.
Generic Brand
Acamprosate Campral
Acetazolamide Diamox
Acitretin Soriatane
Acyclovir Zovirax
Alendronate Fosamax
Alitretinoin Panretin
Almotriptan Axert
Amiloride/hydrochlorothiazide Moduretic
Aminolevulinic acid Levulan Kerastick
Amiodarone Cordarone, Pacerone
Amitriptyline Elavil
Amitriptyline/chlordiazepoxide Limbitro
Amitriptyline/perphenazine Triavil
Amlodipine/atorvastatin Caduet
Amoxapine
Anagrelide Agrylin
Apripiprazole Abilify
Atazanavir Reyataz
Atenolol/chlorthalidone Tenoretic
Atorvastatin Lipitor
Atovaquone/proguanil Malarone
Azatadine/pseudoephedrine Rynatan, Trinalin
Azithromycin Zithromax
Generic Brand
Benazepril Lotensin
Benazepril/hydrochlorothiazide Lotensin HCT
Bendroflumethiazide/nadolol Corzide
Bexarotene Targretin
Bismuth/metronidazole/tetracycline Helidac
Bisoprolol/hydrochlorothiazide Ziac
Brompheniramine/dextromethorphan/phenylephrine Alacol DM
Brompheniramine/dextromethorphan/pseudoephedrine Bromfed-DM
Buffered aspirin/pravastatin Pravigard PAC
Bupropion Wallbutrin, Zyban
Candesartan/hydrochlorothiazide Atacand HCT
Capecitabine Xeloda
Captopril Capoten
Captopril/hydrochlorothiazide Capozide
Carbamazepine Carbatrol, Tegretol, Tegretol-XR
Carbinoxamine/pseudoephedrine Palgic-D, Palgic-DS, Pediatex-D
Carvedilol Coreg
Celecoxib Celebrex
Cetirizine Zyrtec
Cetirizine/pseudoephedrine Zyrtec-D
Cevimeline Evoxac
Chlorhexidine gluconate Hibistat
Chloroquine Aralen
Chlorothiazide Diuril
Chlorphenirmine/hydrocodone/pseudoephedrine Tussend
Chlorpheniramine/phenylephrine/pyrilamine Rynatan
Chlorpromazine Thorazine
Chlorpropamide Diabinese
Chlorthalidone Thalitone
Chlorthalidone/clonidine Clorpres
Cidofovir Vislide
Ciprofloxacin Cipro
Citalopram Celexa
Clemastine Tavist
Clonidine/chlorthalidone Clorpres
Clozapine Clozaril, Fazacio
Cromolyn sodium Gastrocrom
Cyclobenzaprine Flexeril
Cyproheptadine Cyproheptadine
Dacarbazine DTIC-Dome
Dantrolene Dantrium
Demeclocycline Declomycin
Desipramine Norpramin
Diclofenac potassium Catalfam
Diclofenac sodium Voltaren
Diclofenac sodium/misoprostol Arthrotec
Diflunisal Dolobid
Dihydroergotamine D.H.E. 45
Diltiazem Cardizem, Tiazac
Diphenhydramine Benadryl
Divalproex Depakote
Doxepin Sinequan
Doxycycline hyclate Doryx, Periostat, Vibra-Tabs, Vibramycin
Appendix C 1289
Generic Brand
Generic Brand
Generic Brand
Nefazodone Serzone
Nifedipine Adalat CC, Procardia
Nisoldipine Sular
Norfloxacin Noroxin
Nortriptyline Pamelor
Ofloxacin Floxin
Olanzapine Zyprexa
Olanzapine/fluoxetine Symbyax
Olmesartan medoxomil/hydrochlorothiazide Benicar HCT
Olsalazine Dipentum
Oxaprozin Daypro
Oxcarbazepine Trileptal
Oxycodone Roxicodone
Oxytetracycline Terramycin
Pantoprazole Protonix
Paroxetine Paxil
Pastinaca sativa Parsnip
Pentosan polysulfate Elmiron
Pentostatin Nipent
Perphenazine Perphenazine
Pilocarpine Salagen
Piroxicam Feldene
Polythiazide Renese
Polythiazide/prazosin Minizide
Porfimer sodium Photofrin
Pravastatin Pravachol
Prochlorperazine Compazine, Compro
Promethazine Phenergan
Protriptyline Vivactil
Pyrazinamide Pyrazinamide
Quetiapine Seroquel
Quinapril Accupril
Quinapril/hydrochlorethiazide Accuretic
Quinidine gluconate Quinidine
Quinidine sulfate Quinidex
Rabeprazole sodium Aciphex
Ramipril Altace
Riluzole Rilutek
Risperidone Risperdal, Risperdal Consta
Ritonavir Norvir
Rizatriptan Maxalt
Ropinirole Requip
Rosuvastatin Crestor
Ruta graveolens Rue
Saquinavir Fortovase
Saquinavir mesylate Invirase
Selegiline Eldepryl
Sertraline Zoloft
Sibutramine Meridia
Sildenafil Viagra
Simvastatin Zocor
Simvastatin/ezetimibe Vytorin
Somatropin Serostim
Generic Brand
Reprinted with permission from The Drug Topics Red Book. Montvale NJ: Thomson Medical Economics, 2007.
Appendix C 1293
DRUG/ALCOHOL INTERACTIONS
ACETAMINOPHEN ETHANOL 2 2
Concurrent use of ACETAMINOPHEN and ETHANOL may result
in an increased risk of hepatotoxicity.
ACETOPHENAZINE ETHANOL 1 2
Concurrent use of ACETOPHENAZINE and ETHANOL may
result in increased CNS depression and an increased risk of
extrapyramidal reactions.
ACITRETIN ETHANOL 2 1
Concurrent use of ACITRETIN and ETHANOL may result in a
prolonged risk of teratogenicity.
ALFENTANIL ETHANOL 2 2
Concurrent use of ALFENTANOL and ETHANOL may result in
decreased therapeutic effects for alfentanil.
ALPRAZOLAM ETHANOL 1 2
Concurrent use of ALPRAZOLAM and ETHANOL may result in
increased sedation.
AMITRIPTYLINE ETHANOL 1 2
Concurrent use of AMITRIPTYLINE and ETHANOL may result in
enhanced CNS depression and impairment of motor skills.
AMOBARBITAL ETHANOL 1 2
Concurrent use of AMOBARBITAL and ETHANOL may result in
excessive CNS depression.
AMOXAPINE ETHANOL 1 2
Concurrent use of AMOXAPINE and ETHANOL may result in
enhanced drowsiness and impairment of motor skills.
AMPRENAVIR ETHANOL 2 1
Concurrent use of AMPRENAVIR and ETHANOL may result in an
increased risk of propylene glycol toxicity (seizures, tachycardia,
lactic acidosis, renal toxicity, and hemolysis).
APROBARBITAL ETHANOL 1 2
Concurrent use of APROBARBITAL and ETHANOL may result in
excessive CNS depression.
ASPIRIN ETHANOL 1 2
Concurrent use of ASPIRIN and ETHANOL may result in increased
gastrointestinal blood loss.
BUPROPION ETHANOL 2 1
Concurrent use of BUPROPION and ETHANOL may result in an
increased risk of seizures.
BUTABARBITAL ETHANOL 1 2
Concurrent use of BUTABARBITAL and ETHANOL may result in
excessive CNS depression.
BUTALBITAL ETHANOL 1 2
Concurrent use of BUTALBITAL and ETHANOL may result in
excessive CNS depression.
CALAMUS ETHANOL 1 2
Concurrent use of CALAMUS and ETHANOL may result in
increased sedation.
CANNABIS ETHANOL 1 2
Concurrent use of CANNABIS and ETHANOL may result in
increased intoxication.
CARVEDILOL, ETHANOL 1 2
PHOSPHATE Concurrent use of CARVEDILOL, PHOSPHATE and ETHANOL
may result in faster than normal rate of release of
carvedilol phosphate.
CEFAMANDOLE ETHANOL 2 1
Concurrent use of CEFAMANDOLE and ETHANOL may result in
disulfiram-like reactions.
CEFMENOXINE ETHANOL 1 1
Concurrent use of CEFMENOXINE and ETHANOL may result in
disulfiram-like reactions.
CEFOPERAZONE ETHANOL 2 1
Concurrent use of CEFOPERAZONE and ETHANOL may result in
disulfiram-like reactions.
CEFOTETAN ETHANOL 2 1
Concurrent use of CEFOTETAN and ETHANOL may result in
disulfiram-like reactions.
CHAPARRAL ETHANOL 1 2
Concurrent use of CHAPARRAL and ETHANOL may result in
elevated liver transaminases with or without concomitant
hepatic damage.
CHLORAL HYDRATE ETHANOL 1 3
Concurrent use of CHLORAL HYDRATE and ETHANOL may result
in increased sedation.
CHLORDIAZEPOXIDE ETHANOL 1 2
Concurrent use of CHLORDIAZEPOXIDE and ETHANOL may
result in increased sedation.
CHLORPROMAZINE ETHANOL 1 2
Concurrent use of CHLORPROMAZINE and ETHANOL may result
in increased sedation.
CHLORPROPAMIDE ETHANOL 1 1
Concurrent use of CHLORPROPAMIDE and ETHANOL may result
in disulfiram-like reactions.
CIMETIDINE ETHANOL 1 3
Concurrent use of CIMETIDINE and ETHANOL may result in
increased ethanol concentrations.
CISAPRIDE ETHANOL 1 2
Concurrent use of CISAPRIDE and ETHANOL may result in
increased blood levels of ethanol.
CITALOPRAM ETHANOL 0 2
Concurrent use of CITALOPRAM and ETHANOL may result in
potentiation of the cognitive and motor effects of alcohol.
CLOMIPRAMINE ETHANOL 1 2
Concurrent use of CLOMIPRAMINE and ETHANOL may result in
enhanced drowsiness and impairment of motor skills.
CLORAZEPATE ETHANOL 1 2
Concurrent use of CLORAZEPATE and ETHANOL may result in
increased sedation.
COCAINE ETHANOL 1 2
Concurrent use of COCAINE and ETHANOL may result in
increased heart rate and blood pressure.
CODEINE ETHANOL 1 2
Concurrent use of CODEINE and ETHANOL may result in
increased sedation.
COMFREY ETHANOL 1 1
Concurrent use of COMFREY and ETHANOL may result in
elevated inner transaminases with or without concomitant
hepatic damage.
CYCLOSERINE ETHANOL 1 1
Concurrent use of CYCLOSERINE and ETHANOL may result in an
increased risk of seizures.
Appendix C 1295
DESIPRAMINE ETHANOL 1 2
Concurrent use of DESIPRAMINE and ETHANOL may result in
enhanced drowsiness and impairment of motor skills.
DIAZEPAM ETHANOL 1 2
Concurrent use of DIAZEPAM and ETHANOL may result in
increased sedation.
DIMETHINDENE ETHANOL 1 2
Concurrent use of DIMETHINDENE and ETHANOL may result
in increased sedation.
DIPHENHYDRAMINE ETHANOL 1 2
Concurrent use of DIPHENHYDRAMINE and ETHANOL may result
in increased sedation.
DISULFIRAM ETHANOL 1 1
Concurrent use of DISULFIRAM and ETHANOL may result in
ethanol intolerance.
DOTHIEPIN ETHANOL 1 2
Concurrent use of ETHANOL and DOTHIEPIN may result in
enhanced drowsiness and impairment of motor skills.
DOXEPIN ETHANOL 1 2
Concurrent use of DOXEPIN and ETHANOL may result in
enhanced drowsiness and impairment of motor skills.
ESCITALOPRAM ETHANOL 0 2
Concurrent use of ESCITALOPRAM and ETHANOL may result in
potentiation of the cognitive and motor effects of alcohol.
ESZOPICLONE ETHANOL 1 2
Concurrent use of ESZOPICLONE and ETHANOL may result in
impaired psychomotor functions and risk of increased sedation.
ETEROBARB ETHANOL 1 2
Concurrent use of ETEROBARB and ETHANOL may result in
excessive CNS depression.
ETHOPROPAZINE ETHANOL 1 2
Concurrent use of ETHOPROPAZINE and ETHANOL may result in
increased CNS depression and an increased risk of
extrapyramidal reactions.
FLUNITRAZEPAM ETHANOL 1 2
Concurrent use of FLUNITRAZEPAM and ETHANOL may result in
excessive sedation and psychomotor impairment.
FLUPHENAZINE ETHANOL 1 2
Concurrent use of FLUPHENAZINE and ETHANOL may result in
increased CNS depression and an increased risk of
extrapyramidal reactions.
FOMEPIZOLE ETHANOL 2 2
Concurrent use of FOMEPIZOLE and ETHANOL may result in the
reduced elimination of both drugs.
FOSPHENYTOIN ETHANOL 1 2
Concurrent use of FOSPHENYTOIN and ETHANOL may result in
decreased phenytoin serum concentrations, increased seizure
potential, and additive CNS depressant effects.
FURAZOLIDONE ETHANOL 1 1
Concurrent use of FURAZOLIDONE and ETHANOL may result in
disulfiram-like reactions.
GERMANDER ETHANOL 2 1
Concurrent use of GERMANDER and ETHANOL may result in elevated
liver transaminases with or without concomitant hepatic damage.
GLIPIZIDE ETHANOL 1 1
Concurrent use of GLIPIZIDE and ETHANOL may result in
prolonged hypoglycemia and disulfiram-like reactions.
GLICLAZIDE ETHANOL 1 1
Concurrent use of ETHANOL and GLICLAZIDE may result in
prolonged hypoglycemia and disulfiram-like reactions.
GLUTETHIMIDE ETHANOL 1 2
Concurrent use of GLUTETHIMIDE and ETHANOL may result in
increased sedation.
GLYBURIDE ETHANOL 1 2
Concurrent use of GLYBURIDE and ETHANOL may result in
prolonged hypoglycemia and disulfiram-like reactions.
GOSSYPOL ETHANOL 1 2
Concurrent use of GOSSYPOL and ETHANOL may result in delayed
effects of gossypol and/or increased toxic effects of ethanol.
GRISEOFULVIN ETHANOL 1 1
Concurrent use of GRISEOFULVIN and ETHANOL may result in
disulfiram-like reactions.
GUAR GUM ETHANOL 2 2
Concurrent use of GUAR GUM and ETHANOL may result in
increased intoxication effects of ethanol.
GUARANA ETHANOL 1 3
Concurrent use of GUARANA and ETHANOL may result in
increased risk of ethanol intoxication.
HYDROCODONE ETHANOL 1 2
Concurrent use of HYDROCODONE and ETHANOL may result in
increased sedation.
HYDROMORPHONE ETHANOL 1 2
Concurrent use of HYDROMORPHONE and ETHANOL may
result in increased sedation.
IMIPRAMINE ETHANOL 1 2
Concurrent use of IMIPRAMINE and ETHANOL may result in
enhanced drowsiness and impairment of motor skills.
INSULIN ETHANOL 1 2
Concurrent use of INSULIN and ETHANOL may result in
increased hypoglycemia.
INSULIN LISPRO, ETHANOL 1 2
HUMAN Concurrent use of INSULIN LISPRO, HUMAN and ETHANOL and
may result in increased hypoglycemia.
ISONIAZID ETHANOL 2 1
Concurrent use of ISONIAZID and ETHANOL may result in
decreased isoniazid concentrations and disulfiram-like reactions.
ISOTRETINOIN ETHANOL 1 1
Concurrent use of ISOTRETINOIN and ETHANOL may result in
disulfiram-like reactions.
KAVA ETHANOL 1 2
Concurrent use of KAVA and ETHANOL may result in increased
CNS depression and/or increased risk of hepatotoxicity.
KETOCONAZOLE ETHANOL 1 1
Concurrent use of KETOCONAZOLE and ETHANOL may result in
disulfiram-like reactions (flushing, vomiting, increased respiratory
rate, tachycardia).
LOFEPRAMINE ETHANOL 1 2
Concurrent use of LOFEPRAMINE and ETHANOL may result in
enhanced drowsiness and impairment of motor skills.
LORAZEPAM ETHANOL 1 2
Concurrent use of LORAZEPAM and ETHANOL may result in
increased sedation.
Appendix C 1297
MA HUANG ETHANOL 1 1
Concurrent use of MA HUANG and ETHANOL may result in
effects on mental status.
MATE ETHANOL 1 3
Concurrent use of MATE and ETHANOL may result in increased
risk of ethanol intoxication.
MEPERIDINE ETHANOL 1 2
Concurrent use of MEPERIDINE and ETHANOL may result in
increased sedation.
MEPHOBARBITAL ETHANOL 1 2
Concurrent use of MEPHOBARBITAL and ETHANOL may result in
excessive CNS depression.
MEPROBAMATE ETHANOL 1 2
Concurrent use of MEPROBAMATE and ETHANOL may result in
increased sedation.
MESORIDAZINE ETHANOL 1 2
Concurrent use of MESORIDAZINE and ETHANOL may result in
increased CNS depression and an increased risk of
extrapyramidal reactions.
METFORMIN ETHANOL 2 2
Concurrent use of METFORMIN and ETHANOL may result in an
increased risk of lactic acidosis.
METHADONE ETHANOL 1 2
Concurrent use of METHADONE and ETHANOL may result in
increased sedation.
METHOHEXITAL ETHANOL 1 2
Concurrent use of METHOHEXITAL and ETHANOL may result in
excessive CNS depression.
METHOTREXATE ETHANOL 2 2
Concurrent use of METHOTREXATE and ETHANOL may result in
increased hepatotoxicity.
METHOTRIMEPRAZINE ETHANOL 1 2
Concurrent use of METHOTRIMEPRAZINE and ETHANOL may
result in increased CNS depression and an increased risk of
extrapyramidal reactions.
METRONIDAZOLE ETHANOL 1 1
Concurrent use of METRONIDAZOLE and ETHANOL may result in
disulfiram-like reactions (flushing, increased respiratory rate,
tachycardia) or sudden death.
MIRTAZAPINE ETHANOL 1 2
Concurrent use of MIRTAZAPINE and ETHANOL may result in
psychomotor impairment.
MORPHINE ETHANOL 1 2
Concurrent use of MORPHINE and ETHANOL may result in
increased risk of respiratory depression, hypotension,
profound sedation, or coma.
MORPHINE SULFATE ETHANOL 1 1
LIPOSOME Concurrent use of MORPHINE SULFATE LIPOSOME and
ETHANOL may result in increased risk of respiratory depression,
hypotension, profound sedation, or coma.
MOXALACTAM ETHANOL 2 1
Concurrent use of ETHANOL and MOXALACTAM may result in
disulfiram-like reactions.
NEFAZODONE ETHANOL 1 3
Concurrent use of NEFAZODONE and ETHANOL may result in an
increased risk of CNS side effects.
NIACIN ETHANOL 0 2
Concurrent use of NIACIN and ETHANOL may result in increased
side effects of flushing and pruritus.
NILUTAMIDE ETHANOL 1 3
Concurrent use of NILUTAMIDE and ETHANOL may result in an
increased risk of ethanol intolerance (facial flushing, malaise,
and hypotension).
NITROGLYCERIN ETHANOL 1 2
Concurrent use of NITROGLYCERIN and ETHANOL may result
in hypotension.
NORTRIPTYLINE ETHANOL 1 2
Concurrent use of NORTRIPTYLINE and ETHANOL may result in
enhanced drowsiness and impairment of motor skills.
OLANZAPINE ETHANOL 1 2
Concurrent use of OLANZAPINE and ETHANOL may result in
excessive CNS depression.
OXYCODONE ETHANOL 1 2
Concurrent use of OXYCODONE and ETHANOL may result in
increased sedation.
OXYMORPHONE ETHANOL 0 1
Concurrent use of OXYMORPHONE and ETHANOL may result in
increased oxymorphone plasma levels (extended-release
formulation) and additive CNS/ respiratory depression.
PARALDEHYDE ETHANOL 2 2
Concurrent use of PARALDEHYDE and ETHANOL may result
in metabolic acidosis.
PAROXETINE ETHANOL 1 3
Concurrent use of PAROXETINE and ETHANOL may increase the
risk of mental and motor-skill impairment.
PENNYROYAL ETHANOL 1 1
Concurrent use of PENNYROYAL and ETHANOL may result in
elevated liver transaminases with or without concomitant
hepatic damage.
PENTAZOCINE ETHANOL 1 2
Concurrent use of PENTAZOCINE and ETHANOL may result in
increased sedation.
PERPHENAZINE ETHANOL 1 2
Concurrent use of PERPHENAZINE and ETHANOL may result in
increased CNS depression and an increased risk of
extrapyramidal reactions.
PHENELZINE ETHANOL 1 2
Concurrent use of PHENELZINE and ETHANOL may result in
hypertension urgency or emergency.
PHENOBARBITAL ETHANOL 1 2
Concurrent use of PHENOBARBITAL and ETHANOL may result in
excessive CNS depression.
PHENYTOIN ETHANOL 1 2
Concurrent use of PHENYTOIN and ETHANOL may result in
decreased phenytoin serum concentrations, increased seizure
potential, and additive CNS depressant effects.
PIPOTIAZINE ETHANOL 1 2
Concurrent use of PIPOTIAZINE and ETHANOL may result in
increased CNS depression and an increased risk of
extrapyramidal reactions.
PRIMIDONE ETHANOL 1 2
Concurrent use of PRIMIDONE and ETHANOL may result in
excessive CNS depression.
Appendix C 1299
PROCARBAZINE ETHANOL 1 1
Concurrent use of PROCARBAZINE and ETHANOL may result in
disulfiram-like reactions and increased sedation.
PROCHLORPERAZINE ETHANOL 1 2
Concurrent use of PROCHLORPERAZINE and ETHANOL may
result in increased CNS depression and an increased risk of
extrapyramidal reactions.
PROMAZINE ETHANOL 1 2
Concurrent use of PROMAZINE and ETHANOL may result in
increased CNS depression and an increased risk of extrapyramidal
reactions.
PROPIOMAZINE ETHANOL 1 2
Concurrent use of PROPIOMAZINE and ETHANOL may result in
increased CNS depression and an increased risk
of extrapyramidal reactions.
PROTRIPTYLINE ETHANOL 1 2
Concurrent use of PROTRIPTYLINE and ETHANOL may result in
enhanced drowsiness and impairment of motor skills.
QUETIAPINE ETHANOL 1 2
Concurrent use of QUETIAPINE and ETHANOL may result in
potentiation of the cognitive and motor effects of alcohol.
SECOBARBITAL ETHANOL 1 2
Concurrent use of SECOBARBITAL and ETHANOL may result in
excessive CNS depression.
SERTRALINE ETHANOL 1 2
Concurrent use of SERTRALINE and ETHANOL may increase the
risk of mental and motor-skill impairment.
SULFAMETHOXAZOLE ETHANOL 1 1
Concurrent use of SULFAMETHOXAZOLE and ETHANOL may
result in disulfiram-like reactions (flushing, sweating,
palpitations, drowsiness).
TACROLIMUS ETHANOL 1 3
Concurrent use of TACROLIMUS and ETHANOL may result in
alcohol-related flushing and rash.
TADALAFIL ETHANOL 1 2
Concurrent use of TADALAFIL and ETHANOL may result in an
increased risk of hypotension and orthosiatic signs and symptoms.
TEMAZEPAM ETHANOL 1 2
Concurrent use of TEMAZEPAM and ETHANOL may result in
impaired psychomotor functions.
THIETHYLPERAZINE ETHANOL 1 2
Concurrent use of THIETHYLPERAZINE and ETHANOL may
result in increased CNS depression and an increased risk of
extrapyramidal reactions.
THIEOPENTAL ETHANOL 1 2
Concurrent use of THIEOPENTAL and ETHANOL may result in
excessive CNS depression.
THIORIDAZINE ETHANOL 1 2
Concurrent use of THIORIDAZINE and ETHANOL may result in
increased CNS depression and an increased risk of
extrapyramidal reactions.
TIZANIDINE ETHANOL 1 2
Concurrent use of TIZANIDINE and ETHANOL may increase the
risk of tizanidine adverse effects (excessive CNS depression).
TOLAZAMIDE ETHANOL 1 1
Concurrent use of TOLAZAMIDE and ETHANOL may result in
prolonged hypoglycemia and disulfiram-like reactions.
TOLAZOLINE ETHANOL 2 1
Concurrent use of TOLAZOLINE and ETHANOL may result in
disulfiram-like reactions.
TOLBUTAMIDE ETHANOL 1 1
Concurrent use of TOLBUTAMIDE and ETHANOL may result in
prolonged hypoglycemia and disulfiram-like reactions.
TRAMADOL ETHANOL 1 2
Concurrent use of TRAMADOL and ETHANOL may increase the
risk of excessive CNS depression.
TRANYLCYPROMINE ETHANOL 1 2
Concurrent use of TRANYLCYPROMINE and ETHANOL may result
in hypertensive urgency or emergency.
TRIAZOLAM ETHANOL 1 2
Concurrent use of TRIAZOLAM and ETHANOL may result
in increased sedation.
TRIFLUPERAZINE ETHANOL 1 2
Concurrent use of TRIFLUPERAZINE and ETHANOL may result in
increased CNS depression and an increased risk of
extrapyramidal reactions.
TRIFLUPROMAZINE ETHANOL 1 2
Concurrent use of TRIFLUPROMAZINE and ETHANOL may result
in increased CNS depression and an increased risk of
extrapyramidal reactions.
TRIMETHOPRIM ETHANOL 1 1
Concurrent use of ETHANOL and COTRIMOXAZOLE may result
in disulfiram-like reactions.
TRIMIPRAMINE ETHANOL 1 2
Concurrent use of TRIMIPRAMINE and ETHANOL may result in
enhanced drowsiness and impairment of motor skills.
VALERIAN ETHANOL 1 2
Concurrent use of VALERIAN and ETHANOL may result in
increased sedation.
VENLAFAXINE ETHANOL 1 3
Concurrent use of VENLAFAXINE and ETHANOL may result in an
increased risk of CNS effects.
VERAPAMIL ETHANOL 1 2
Concurrent use of VERAPAMIL and ETHANOL may result in
enhanced ethanol intoxication (impaired psychomotor functioning).
WARFARIN ETHANOL 2 2
Concurrent use of WARFARIN and ETHANOL may result in increased
or decreased international normalized ratio (INR) or prothrombin time.
YOHIMBINE ETHANOL 1 2
Concurrent use of YOHIMBINE and ETHANOL may result in
increased ethanol intoxication and increased anxiety
and blood pressure.
ZALEPLON ETHANOL 1 2
Concurrent use of ZALEPLON and ETHANOL may result in
impaired psychomotor functions.
ZOLPIDEM ETHANOL 1 2
Concurrent use of ZOLPIDEM and ETHANOL may result
in increased sedation.
ONSET: 0 5 Unspecified
1 5 Rapid (within 24 hours)
2 5 Delayed (after 24 hours)
SEVERITY: 1 5 Major (possibly life threatening or potential permanent damage)
2 5 Moderate (may exacerbate patient’s condition)
3 5 Minor (little if any clinical effect)
Note: Disulfiram-like reactions include nausea, vomiting, diarrhea, flushing, tachycardia, and hypotension. Reprinted with permission from The Drug Topics Red
Book. Montvale, NJ: Thomson Medical Economics, 2007.
Appendix C 1301
DRUG/TOBACCO INTERACTIONS
Product Interaction Onset Severity
ALPRAZOLAM TOBACCO 0 2
Concurrent use of ALPRAZOLAM and TOBACCO may
result in decreased alprazolam plasma concentrations
and efficacy.
CONTRACEPTIVES, COMBINATION TOBACCO 2 3
Concurrent use of CONTRACEPTIVES,
COMBINATION and TOBACCO may result in an
increased risk of cardiovascular disease.
ERLOTINIB TOBACCO 0 2
Concurrent use of ERLOTINIB and TOBACCO may
result in increased erlotinib clearance and reduced
serum concentrations.
FLUVOXAMINE TOBACCO 2 3
Concurrent use of FLUVOXAMINE and TOBACCO
may result in increased fluvoxamine metabolism.
IMIPRAMINE TOBACCO 2 2
Concurrent use of IMIPRAMINE and TOBACCO may
result in decreased imipramine concentrations.
PENTAZOCINE TOBACCO 2 2
Concurrent use of PENTAZOCINE and TOBACCO may
result in decreased pentazocine concentrations.
PROPOXYPHENE TOBACCO 2 2
Concurrent use of PROPOXYPHENE and TOBACCO
may result in decreased propoxyphene concentrations.
ROPINIROLE TOBACCO 0 2
Concurrent use of ROPINIROLE and TOBACCO may
result in decreased ropinirole plasma concentrations
and efficacy.
THEOPHYLLINE TOBACCO 2 2
Concurrent use of THEOPHYLLINE and TOBACCO
may result in decreased theophylline concentrations.
TOLBUTAMIDE TOBACCO 2 2
Concurrent use of TOLBUTAMIDE and TOBACCO may
result in decreased tolbutamide concentrations.
WARFARIN TOBACCO 2 2
Concurrent use of WARFARIN and TOBACCO
may result in increased or decreased international
normalized ratio (INR) or prothrombin time.
ONSET: 0 5 Unspecified
1 5 Rapid (within 24 hours)
2 5 Delayed (after 24 hours)
SEVERITY: 1 5 Major (possibly life threatening or potential permanent damage)
2 5 Moderate (may exacerbate patient’s condition)
3 5 Minor (little if any clinical effect)
Note: Disulfiram-like reactions include nausea, vomiting, diarrhea, flushing, tachycardia, and hypotension. Reprinted with permission from The Drug Topics Red
Book. Montvale, NJ: Thomson Medical Economics, 2007.
1302 Appendix C
USE-IN-PREGNANCY RATINGS has ruled out risk to the fetus against the drug’s potential ben-
The U.S. Food and Drug Administration’s Use-in-Pregnancy efit to the patient. Below is a listing of drugs (by generic name)
rating system weighs the degree to which available information for which ratings are available.
Reprinted with permission from The Drug Topics Red Book. Montvale NJ: Thomson Medical Economics, 2006.
1310 Appendix C
Reprinted with permission from The Drug Products Red Book. Montvale NJ: Thomson Medical Economics, 2007.
Appendix C 1313
Vegetables All fresh, frozen, canned, or Chili peppers, Sauerkraut, broad or fava bean pods
dried vegetable juices except Chinese pea pods (not beans)
those not allowed
Fruit Fresh, frozen, or canned fruits Avocado, figs Banana peel, avocado (over-ripened)
and fruit juices
Soups All soups not listed to limit None Soups which contain aged cheese, tap
or avoid beer, any made with flavor cubes or
meat extract, miso soup, broad or
fava bean pods (not beans)
Fats All except fermented None None
Sweets Sugar, hard candy, honey, None None
molasses, syrups, chocolate
candy
Desserts Cakes, cookies, gelatin, pastries, None None
sherbets, sorbets, chocolate
desserts
Miscellaneous Salt, nuts, spices, herbs, Peanuts Soy sauce, all aged and fermented
flavorings, Worcestershire products, marmite and other
sauce, Brewer’s or Baker’s concentrated yeast extracts
yeast, monosodium glutamate,
vitamins with Brewer’s yeast
1
Freshness is of primary importance. Food that is spoiled or improperly stored should be avoided. Copyright © 1978-2008 Lexi-Comp Inc. All Rights Reserved.
REFERENCES
Shulman KI and Walker SE, “A Reevaluation of Dietary Re- Walker SE, Shulman KI, Tailor SAN, et al., “Tyramine Con-
strictions for Irreversible Monoamine Oxidase Inhibitors” tent of Previously Restricted Foods in Monoamine Oxidase
Psychiatr Ann, 2001, 31(6):378–84. Inhibitor Diets,” J Clin Psychopharmacol, 1996, 16(5):383–8.
Shulman KI and Walker SE, “Refining the MAOI Diet: Tyra-
mine Content of Pizza and Soy Products,” J Clin Psychiatry,
1999, 60(3):191–3.